iBio Scales Up Green Manufacturing

New iBio CMO co-funded by Eastern Capital Limited prepares 139,000-sq-ft production facility for commercial-scale biotherapeutics manufacturing.

Pall Prepares to Open U.K. Life Sciences Center

Officials at Pall say the company is building a life sciences center of excellence (COE) at its new Harbourgate site in Portsmouth, U.K.

Lonza to Manufacture OncoMed’s Anticancer Antibody Pipeline

Lonza and OncoMed Pharmaceuticals signed a process development and manufacturing collaboration for the latter’s anticancer monoclonal antibody candidates, and a multi-product licensing deal that will give OncoMed a license to Lonza’s GS Gene Expression System™, and Version 8 media and feeds manufacturing platform.

Amgen Opens Novel Biomanufacturing Facility in Singapore

The facility is expected to have the same annual output as a conventional facility but in a single building.

Lilly Injects $700M into Manufacturing More Insulin

Eli Lilly and Co. are going to invest over $700 million to enhance its global insulin manufacturing capacity in Puerto Rico, France, and China, as well as Indianapolis.

Promega Plans 260,000-Square-Foot Facility for Molecular Bio Products

Plans are for 260,000 square feet with committed production lines.

Danaher to Acquire GE Life Sciences’ Biopharma Business for $21.4B

Danaher agreed to buy GE Life Sciences biopharma business for approximately $21.4 billion cash, in a deal designed to enhance the buyer’s bioprocessing offerings and pay down the seller’s debt. Following completion of the acquisition, GE Biopharma will operate as a standalone company within Danaher’s Life Sciences segment

Medicago Wins $21M DARPA Award to Scale Up Production of Flu Vaccines

90,000 sq. ft. facility is to be built for the manufacture of 10 million doses/month.

Gene Expression Controlled by Nano Soccer Balls

Gene expression may be controlled by transcription factor clusters that reduce promoter search times through intersegment transfer.

Renova to Develop Transgenic Rabbits for Pharming’s Recombinant FVIII Program

Maryland firm announced birth of rhFVII transgenic rabbits at Chinese subsidiary.

Recently Featured

Stay Connected

Scroll Up